ImmunityBio has received approval from the Macau Special Administrative Region for Anktiva in combination with BCG for ...

BMS's Opdivo has received approvals for two new indications in cHL from the US FDA and the EC, expanding its use for both paediatric and adult patients.

Novartis has signed an agreement to acquire SNV4818, a pan-mutant selective Phosphoinositide 3-kinase alpha (PI3Kα) inhibitor ...

J&J’s Icotyde will take on AbbVie’s blockbuster injectable Skyrizi as analysts forecast a blockbuster future for the pill.

An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...

R1 Therapeutics has raised $77.5m in an oversubscribed Series A funding to advance AP306 for hyperphosphatemia in CKD ...

The FDA has issued a CRL to Aldeyra Therapeutics for its new drug application (NDA) of reproxalap to treat dry eye disease.

GSK's RSV jab, Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA across the high-risk ...

The court ruling reverses several changes by the CDC’s vaccine panel to childhood immunisation recommendations.

While the FDA can legally make prescription drugs OTC, legal expert Heidi Gertner notes that this wider shift depends on ...

In a recent article, Sanofi presented preclinical data for an in vivo CAR-T platform that reengineers T cells directly within the body.

Sentynl Therapeutics has signed an agreement with PRG S&T to license Progerinin, an investigational molecule intended to ...